ZIM Laboratories Limited (NSE:ZIMLAB)
India · Delayed Price · Currency is INR 125.50
-2.52 (-1.97%)
Sep 4, 2026, 3:29 PM IST
ZIM Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6,723 | 3,203 | 3,908 | 4,653 | 3,528 | 2,596 | |
Market Cap Growth | 82.17% | -18.03% | -16.02% | 31.91% | 35.88% | 120.48% |
Enterprise Value | 7,586 | 4,386 | 4,892 | 5,106 | 4,096 | 3,423 |
Last Close Price | 125.50 | 60.26 | 80.53 | 94.95 | 72.25 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 181.89 | 54.87 | 32.12 | 26.98 | 14.44 | 17.84 |
PS Ratio | 1.69 | 0.86 | 1.03 | 1.27 | 0.89 | 0.78 |
PB Ratio | 2.27 | 1.08 | 1.55 | 1.95 | 1.76 | 1.48 |
P/TBV Ratio | 2.65 | 1.26 | 1.78 | 2.15 | 1.89 | 1.57 |
P/FCF Ratio | 130.61 | 62.22 | 1094.93 | - | 235.14 | 7.64 |
P/OCF Ratio | 13.57 | 6.47 | 9.49 | 28.59 | 9.24 | 5.28 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.91 | 1.17 | 1.29 | 1.39 | 1.03 | 1.03 |
EV/EBITDA Ratio | 27.93 | 17.66 | 12.40 | 13.07 | 8.21 | 8.82 |
EV/EBIT Ratio | 95.04 | 42.59 | 19.99 | 19.89 | 11.62 | 13.67 |
EV/FCF Ratio | 147.37 | 85.21 | 1370.65 | - | 273.04 | 10.07 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.43 | 0.43 | 0.47 | 0.47 | 0.31 | 0.30 |
Debt / EBITDA Ratio | 4.66 | 4.28 | 2.68 | 2.72 | 1.18 | 1.30 |
Debt / FCF Ratio | - | 24.59 | 330.06 | - | 41.43 | 1.57 |
Net Debt / Equity Ratio | 0.29 | 0.29 | 0.46 | 0.43 | 0.28 | 0.28 |
Net Debt / EBITDA Ratio | 3.85 | 3.48 | 2.93 | 2.61 | 1.12 | 1.29 |
Net Debt / FCF Ratio | - | 16.77 | 324.36 | -1.77 | 37.15 | 1.47 |
Asset Turnover | - | 0.74 | 0.83 | 0.93 | 1.17 | 1.00 |
Inventory Turnover | - | 1.96 | 2.10 | 2.69 | 3.21 | 2.58 |
Quick Ratio | - | 0.78 | 0.66 | 0.71 | 0.95 | 0.69 |
Current Ratio | - | 1.45 | 1.39 | 1.43 | 1.72 | 1.45 |
Return on Equity (ROE) | - | 2.13% | 4.96% | 7.85% | 13.00% | 8.65% |
Return on Assets (ROA) | - | 1.27% | 3.33% | 4.07% | 6.45% | 4.70% |
Return on Invested Capital (ROIC) | 1.52% | 1.95% | 4.67% | 6.28% | 10.12% | 7.41% |
Return on Capital Employed (ROCE) | - | 3.00% | 8.00% | 8.90% | 15.30% | 12.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.55% | 1.82% | 3.11% | 3.71% | 6.93% | 5.60% |
FCF Yield | 0.77% | 1.61% | 0.09% | -12.39% | 0.43% | 13.09% |
Payout Ratio | - | - | - | 0.29% | 0.24% | 1.15% |
Buyback Yield / Dilution | -2.98% | -0.52% | - | - | - | -0.09% |
Total Shareholder Return | -2.98% | -0.52% | - | - | - | -0.09% |